Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results

B Processed 3,177 EsoGuardĀ® tests and recognized 1Q26 revenue of $1.3 million, ending quarter with $45 million in proforma cash and a runway that extends…
posteditor
posteditor
Articles: 17424

Other News